Today: 20 May 2026
Nike stock closes above $65 as sneaker-demand debate flares and jobs data looms
7 January 2026
1 min read

Nike stock closes above $65 as sneaker-demand debate flares and jobs data looms

NEW YORK, January 6, 2026, 21:23 (ET) — Market closed

  • Nike shares rose 1.27% in the regular session and slipped slightly after hours.
  • A Bank of America downgrade of Adidas revived questions about what consumers want in footwear.
  • Investors turn next to U.S. labor-market data on Wednesday and Friday.

Nike, Inc. (NKE) shares closed up 1.27% at $65.35 on Tuesday, and were last down 0.12% at $65.27 in after-hours trading, which takes place after the regular session ends. The stock traded between $63.41 and $65.43 and is up about 3.3% from its Jan. 2 close.

The move keeps Nike stock on traders’ screens after a volatile stretch in late December, when investors punished the company for margin pressure and a slow recovery in key categories. For now, the tape is rewarding signs the stock can hold ground above $65 without fresh company news.

Nike said last month that second-quarter revenue rose 1% to $12.4 billion, but gross margin — a key measure of profitability — fell 3 percentage points to 40.6%. CEO Elliott Hill said Nike was in the “middle innings of our comeback,” while CFO Matthew Friend pointed to headwinds from repositioning the business.

A fresh round of sector commentary also fed into the session. Bank of America analyst Thierry Cota double-downgraded Adidas and cut his price target, saying the sneaker “casualization trend has peaked,” MarketWatch reported, highlighting how quickly sentiment can swing across sportswear names.

The broader backdrop was supportive. Major stock indexes pushed to record highs on Tuesday as investors looked ahead to market data this week that could shape expectations for Federal Reserve policy.

Nike’s shares sit within a 52-week range of $52.28 to $82.44, Investing.com data show. The same data show Nike is set to release its next earnings report on March 19.

But the rebound remains vulnerable if investors see more discounting in footwear and apparel, or if tariffs and supply-chain costs keep squeezing margins. Reuters reported after Nike’s last results that the company was still wrestling with margin pressure as it works through its turnaround.

Ahead of Wednesday’s U.S. session, investors will focus on the Job Openings and Labor Turnover Survey for November, due at 10:00 a.m. ET, and Friday’s nonfarm payrolls report for December. Those releases can move rate bets and, in turn, appetite for consumer-discretionary stocks such as Nike.

Stock Market Today

  • Applied Digital, Viasat, CECO Environmental, and HNI Shares Plunge Amid Rising Yields and Oil Prices
    May 20, 2026, 5:35 PM EDT. Applied Digital (APLD), Viasat, CECO Environmental, and HNI stocks suffered sharp declines in afternoon trading due to surging 10-year Treasury yields hitting 4.56%, a one-year high, and rising WTI crude oil prices near $104 per barrel amid geopolitical tensions. The market also reacted negatively to the lack of concrete agreements from the recent U.S.-China summit. Applied Digital remains notable, trading near its 52-week high at $42.53 after signing long-term AI data center deals expected to generate $7 billion in revenue over 15 years, reflecting strong positioning in the growing AI infrastructure sector. The broader sell-off weighed on major indexes, including the S&P 500 and Nasdaq, pulling them back from record highs.

Latest articles

Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

20 May 2026
Immunovant shares jumped 35.3% to $35.56 after reporting 16-week data showing its drug IMVT-1402 produced ACR20, ACR50, and ACR70 response rates of 72.7%, 54.5%, and 35.8% in difficult-to-treat rheumatoid arthritis. Roivant Sciences, its majority owner, rose 14.9%. No new safety signals were reported. The trial enrolled 170 patients, most of whom had failed two prior advanced therapies.
FuelCell Energy surges as AI-fueled rally hits again, analysts wary

FuelCell Energy surges as AI-fueled rally hits again, analysts wary

20 May 2026
FuelCell Energy shares surged 16.5% to $20.22 Wednesday, rebounding after a two-day selloff. The move tracked a 1.5% gain in the Nasdaq Composite and renewed interest in companies supplying power to AI data centers. FuelCell reported a $26.1 million quarterly loss and a declining backlog, despite higher revenue and new data-center proposals. Peers traded mixed, with Bloom Energy up and Plug Power down.
e.l.f. Beauty Earnings Beat Comes With a Catch for Wall Street

e.l.f. Beauty Earnings Beat Comes With a Catch for Wall Street

20 May 2026
e.l.f. Beauty forecast fiscal 2027 sales and adjusted profit below Wall Street estimates, citing $15–$20 million in potential oil-related costs from the Iran war. Fourth-quarter net sales rose 35% to $449.3 million, beating expectations, but the company posted a $49.4 million net loss due to a $57.6 million charge tied to the Rhode acquisition. Shares rose after hours despite closing down 4.3% earlier.
Vertiv stock (VRT) whipsaws after Nvidia CES cooling claim; earnings next in focus
Previous Story

Vertiv stock (VRT) whipsaws after Nvidia CES cooling claim; earnings next in focus

Cipla share price slides after USFDA flags Pharmathen: what the Form 483 says
Next Story

Cipla share price slides after USFDA flags Pharmathen: what the Form 483 says

Go toTop